Scientific advancements are critical for unlocking incredible breakthroughs in global health. That's why ATCC is committed to providing researchers with the credible, cutting-edge models they need to make breakthroughs in diagnostics development, drug discovery, and translational research.
Through targeted acquisitions, we are able to provide researchers with clinically relevant microorganisms and patient-derived cell lines that support important public health initiatives such as antimicrobial resistance, infectious disease, and cancer research. We also conduct our own internal research using the latest techniques and technologies to drive the development of innovative products that provide greater specificity and functionality to the researcher's toolkit.
Explore our newest products below to discover how we can collaborate on your next project, and be sure to check out our resources for detailed product application data.